UCC Representations and Warranties. Lessee and Guarantor represent and warrant to the Lessor that:
UCC Representations and Warranties. Seller’s exact legal name is, and since its formation has been, “APR Applied Pharma Research S.A.”. Seller has no office, ongoing operations or physical assets located within the United States, and Seller’s registered office is Xxx Xxxxx 0, 0000 Xxxxxxx, Xxxxxxxxxxx, and since its formation has been registered in Switzerland.
UCC Representations and Warranties. Seller’s exact legal name is, and for the shorter of its existence as a company or the immediately preceding ten (10) years has been, “ AMARIN PHARMACEUTICALS IRELAND LIMITED” The Seller is, and for the shorter of its existence as a company or the immediately preceding ten (10) years has been, incorporated under the laws of Ireland.
UCC Representations and Warranties. Vertex’s exact legal name is, and for the immediately preceding 10 years has been, “Vertex Pharmaceuticals Incorporated”. The principal place of business and chief executive office of Vertex for the immediately preceding 10 years and the office where it keeps its books and records relating to the Purchased Interest are located at the address(es) set forth on Schedule 3.13 attached hereto. Vertex’s Massachusetts organizational identification number and Federal Employer Identification Number are as set forth on Schedule 3.13 attached hereto.
UCC Representations and Warranties. Seller’s exact legal name is, and has always been “VIVUS, Inc.”. The principal place of business and principal executive offices of Seller where it keeps its books and records relating to the Qsymia Product Rights is, as has been for the preceding five (5) years, located at 0000 Xxxxxx Xxxxxx, Mt. View, California 94040. Seller’s Delaware organizational identification number is 2624559 and its Federal Employer Identification Number is 00-0000000.
UCC Representations and Warranties. Seller’s exact legal name is “Galera Therapeutics, Inc.” The principal place of business and principal executive offices of Seller have been, and the office where it keeps its books and records relating to the Purchased Receivables has been, located at 0 Xxxx Xxxxxxx Xxxxxxxxx, Xxxxx 000, Xxxxxxx, XX 00000. Seller’s Federal Employer Identification Number is 00-0000000. Seller has not changed its jurisdiction of organization in the five (5) years prior to the Effective Date.
UCC Representations and Warranties. Seller’s exact legal name is, and since its formation has been, “InSite Vision Incorporated.” Seller’s location, for purposes of Section 9-307 of the UCC is, and since its formation has been, Delaware.
UCC Representations and Warranties. (a) Seller’s exact legal name is, and for the preceding ten years has been, “Xencor, Inc.”
UCC Representations and Warranties. The Borrower’s exact legal name is, and has always been, “Curis Royalty LLC”. Curis’ exact legal name is, and, since August 1, 2000, has been, “Curis, Inc.” The principal place of business and chief executive office of the Borrower has always been, and the office where it keeps its books and records relating to the License Agreement are located at, the address of the Borrower set forth in Section 9.01 hereof. The Borrower’s Delaware organizational identification number and Federal Employer Identification Number are 5245460 and 00-0000000, respectively.
UCC Representations and Warranties. It is the express intent of the parties hereto that the conveyance of the Underlying Securities by the Depositor to the Trustee be, and be construed as, a sale of the Underlying Securities by the Depositor and not a pledge of any Underlying Securities by the Depositor to secure a debt or other obligation of the Depositor. In the event that, notwithstanding the aforementioned intent of the parties, any Underlying Securities are held to be property of the Depositor, then, it is the express intent of the parties that such conveyance be deemed a pledge of such Underlying Securities by the Depositor to the Trustee to secure a debt or other obligation of the Depositor, pursuant to Section 10.07 of the Standard Terms. In connection with any such grant of a security interest in the Underlying Securities, Depositor hereby represents and warrants to Trustee as follows:
